Development of Resistance to B-Cell Depletion Following Ten Years of Effective Rituximab Treatment in a Patient with Neuromyelitis Optica

被引：0
|
作者：
Harel, Asaff [1 ]
Nursey, Vishaan [2 ]
Stern, Joel [2 ]
Najjar, Souhel [1 ]
机构：
[1] Northwell Hlth Partners, Neurol, New York, NY USA
[2] Feinstein Inst Med Res, Mol Med, Manhasset, NY USA
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1.2-008
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Correlation of B-cell depletion and disease activity after treatment with rituximab in patients with neuromyelitis optica
    Pellkofer, H. L.
    Hohlfeld, R.
    Kuempfel, T.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S130 - S131
  • [2] B-cell depletion therapy using rituximab in neuromyelitis optica spectrum disorders
    Kim, H. J.
    Kim, W.
    Park, M. S.
    Ha, C. K.
    Jung, I. J.
    Lee, K. I.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S253 - S254
  • [3] Severe Relapse Despite B-Cell Depletion in Neuromyelitis Optica
    Riley, Claire
    Tullman, Mark
    [J]. NEUROLOGY, 2010, 74 (09) : A171 - A171
  • [4] T cell suppression following treatment with rituximab in neuromyelitis optica
    Genain, Claude P.
    Islar, Janeen
    Gardell, Jennifer
    Delgadillo, Aracely
    Ross, Michael
    Cree, Bruce C.
    [J]. ANNALS OF NEUROLOGY, 2007, 62 : S70 - S70
  • [5] Minimal effect of rituximab dose on duration of B cell depletion in neuromyelitis optica
    Havla, J.
    Pellkofer, H.
    Schuh, E.
    Gerdes, L.
    Meinl, I.
    Hohlfeld, R.
    Kuempfel, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 492 - 492
  • [6] Duration of B-cell depletion in patients receiving ocrelizumab or rituximab for Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorders
    AbdelRazek, M. A.
    Casasola, M.
    Mollashahi, R.
    Brodski, A.
    Morin, S.
    Augustynowicz, A.
    Jassim, S.
    Matiello, M.
    Sloane, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 100 - 100
  • [7] T-cell suppression following treatment with rituximab in neuromyelitis optica
    Genain, C.
    Isla, J.
    Gardell, J.
    Delgadillo, A.
    Ross, M.
    Kornyeyeva, E.
    Cree, B.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S164 - S164
  • [8] Lofgren syndrome as secondary autoimmune disease in a patient with B-cell depletion following rituximab treatment
    Kronbichler, A.
    Luger, A. K.
    Loacker, L.
    Pizzini, A.
    Loeffler-Ragg, J.
    Peschel, I.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : 515 - 516
  • [9] Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder
    Sechi, Elia
    Zarbo, Roberto
    Biancu, Maria Angela
    Chessa, Paola
    Idda, Maria Laura
    Orru, Valeria
    Lai, Sandra
    Leoni, Stefania
    Solla, Paolo
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2021, 358
  • [10] Effects of B-cell depletion on T-cell subsets and function in neuromyelitis optica
    Genain, Claude P.
    Islar, Janeen
    Gardell, Jennifer
    Ross, Michael
    Korynyeya, Elena
    Cree, Bruce A.
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S11 - S11
12345